Drug Discovery News
-
Korea offers niclosamide-based drug as possible cure for COVID-19 variants
Drug Discovery | News | 0 Comment | 08 Dec, 2021
Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...Read more
-
Standigm, Institut Pasteur Korea team up for AI-based drug discovery research on TB
Drug Discovery | News | 0 Comment | 02 Dec, 2021
South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Institut P...Read more
-
Tackling onerousness drug development process through cost-effective genomic analysis platforms
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 02 Dec, 2021
The limitations of the existing drug discovery paradigm reveals that there are still no effective prevention or real cur...Read more
-
Holistic drug development strategy improves probability of success in oncology therapeutics
Drug Discovery | Opinion | By Hithaishi C Bhaksar | 2 Comment | 22 Nov, 2021
AUM Biosciences is a global clinical-stage biotech company, focused on discovering and developing novel target...Read more
-
Pfizer inks deal worth $5.29 B with US government for COVID-19 pill
Drug Discovery | News | 0 Comment | 19 Nov, 2021
Pfizer Inc. has announced an agreement with the US government to supply 10 million treatment courses of its investi...Read more
-
Pfizer seeks EUA for novel oral COVID-19 pill
Drug Discovery | News | 0 Comment | 17 Nov, 2021
Pfizer Inc. has announced that it is seeking Emergency Use Authorization (EUA) of its investigational oral antivira...Read more
-
Korea's GI Innovation inks MoU with Merck for bio drug development
Drug Discovery | News | 0 Comment | 10 Nov, 2021
South Korea-based GI Innovation has inked a biopharmaceutical manufacturing and development based Memorandum o...Read more
-
AUM Biosciences raises $27M “Series A” fund to advance precision cancer therapies
Drug Discovery | News | 0 Comment | 13 Oct, 2021
Singapore's AUM Biosciences (AUM) has completed of $27 million series A funding round to develop a drug pipeline focused...Read more
-
Israel's CytoReason introduces AI clinical drug development platform to Japan’s pharma market
Drug Discovery | News | 0 Comment | 30 Sep, 2021
CytoReason, an AI company developing computational disease models for discovery and clinical drug development, and Summi...Read more
-
Japan sets eyes on rare pediatric liver diseases
Drug Discovery | News | 0 Comment | 22 Sep, 2021
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...Read more
-
Drug Discovery | News | 0 Comment | 17 Sep, 2021
SuperTrans Medical ("STM"), an Australian biopharmaceutical company developing novel antibiotics that target difficult-t...Read more
-
BC Platforms to enable longitudinal RWD and Genomics access for drug development in Africa
Drug Discovery | News | 0 Comment | 13 Sep, 2021
BC Platforms (BCP), a global leader in genomics research, analytics and global data access, announced a new collabo...Read more
-
French firm Poxel launches type 2 diabetes drug in Japan
Drug Discovery | News | 0 Comment | 10 Sep, 2021
French firm POXEL SA along with its partner, Sumitomo Dainippon Pharma, is launching TWYMEEG (Imeglimin hydro...Read more
-
Drug Discovery | Opinion | 4 Comment | 06 Sep, 2021
What unique initiatives are being taken by the company to connect microbiome with human health? Which are the major ther...Read more
-
Taiwan's Centre for Drug Evaluation initiates new drug trial against COVID-19
Drug Discovery | News | 1 Comment | 16 Aug, 2021
US-based Senhwa Biosciences, Inc. has announced that its novel oral drug, Silmitasertib, has been included in Taiwa...Read more
-
Healx’s AI-platform to create world’s most detailed rare disease biomedical knowledge graph
Drug Discovery | News | 1 Comment | 10 Aug, 2021
Healx, the AI-powered, UK-founded global drug discovery company, has entered a partnership with Japan's Ono Pharmace...Read more
-
Japan's Otsuka Pharma receives $17.8 M grant for TB drug trial
Drug Discovery | News | 1 Comment | 10 Aug, 2021
Otsuka Pharmaceutical Development & Commercialization, Inc., a subsidiary of Japan-based Otsuka Pharmaceutical, has ...Read more
-
Chinese firms to advance drug development for hard-to-drug molecular targets
Drug Discovery | News | 1 Comment | 09 Aug, 2021
Hong Kong's Antengene Corporation Limited, a biopharmaceutical company focused on hematology and oncology drugs is ...Read more
